Immunocore Holdings plc (IMCR) Net Margin
- 2026-06-30: Net Margin -0.70%.
- 2026-03-31: Net Margin 12.16%.
- 2025-12-31: Net Margin -28.77%.
- 2025-09-30: Net Margin -0.17%.
Complete source-backed net margin history.
- Available history
- 2021-12-31 to 2026-06-30
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2026-06-30 | -0.70% |
| 2026-03-31 | 12.16% |
| 2025-12-31 | -28.77% |
| 2025-09-30 | -0.17% |
| 2025-06-30 | -10.51% |
| 2025-03-31 | 5.35% |
| 2024-12-31 | -28.28% |
| 2024-09-30 | 10.89% |
| 2024-06-30 | -15.41% |
| 2024-03-31 | -34.66% |
| 2023-12-31 | -28.12% |
| 2023-09-30 | 1.40% |
| 2023-06-30 | -28.47% |
| 2023-03-31 | -35.58% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -8.88% |
| 2024-12-31 | -16.47% |
| 2023-12-31 | -22.17% |
| 2022-12-31 | -30.13% |
| 2021-12-31 | -4414.64% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |